CD19-specific CAR-T cell therapies are the gold standard of adoptive cellular immunotherapy for hematopoietic malignancies. In Science Translational Medicine, Park et al. develop an oncolytic vaccinia virus that introduces truncated CD19 expression in solid tumors, which are then eradicated by CD19-specific CAR-T cells in immunodeficient and immunocompetent mouse models.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ccell.2020.10.003 | DOI Listing |
Publication Analysis
Top Keywords
solid tumors
8
cd19-specific car-t
8
combination therapy
4
therapy solid
4
tumors classic
4
classic car
4
car adventures
4
adventures cd19-specific
4
car-t cell
4
cell therapies
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!